Abstract:The viral capsid performs critical functions during HIV-1 infection and is a validated target for antiviral therapy. Previous studies have established that the proper structure and stability of the capsid are required for efficient HIV-1 reverse transcription in target cells. Moreover, it has recently been demonstrated that permeabilized virions and purified HIV-1 cores undergo efficient reverse transcription in vitro when the capsid is stabilized by addition of the host cell metabolite inositol hexakisphosphate (IP6). However, the molecular mechanism by which the capsid promotes reverse transcription is undefined. Here we show that wild type HIV-1 virions can undergo efficient reverse transcription in vitro in the absence of a membrane-permeabilizing agent. This activity, originally termed "natural endogenous reverse transcription" (NERT), depends on expression of the viral envelope glycoprotein during virus assembly and its incorporation into virions. Truncation of the gp41 cytoplasmic tail markedly reduced NERT activity, suggesting that gp41 licenses the entry of nucleotides into virions. By contrast to reverse transcription in permeabilized virions, NERT required neither the addition of IP6 nor a mature capsid, indicating that an intact viral membrane can substitute for the function of the viral capsid during reverse transcription in vitro . Collectively, these results demonstrate that the viral capsid functions as a nanoscale container for reverse transcription during HIV-1 infection. HIV-1 infection is critically dependent on reverse transcription, or copying of the viral RNA into DNA, following entry of the viral core in target cells. Reverse transcription depends on the stability of the capsid, yet the precise function the capsid serves during the reaction has not been established. Here we show that the viral capsid functions as a container for the reaction. Addition of dNTPs to intact virions in the absence of a permeabilizing agent resulted in efficient reverse transcription (NERT). Analysis of HIV-1 mutants revealed that the reaction depends on the cytoplasmic domain of gp41, confirming an earlier report. By contrast to the reaction in permeabilized virions, NERT required neither a stable nor a mature capsid, nor was it affected by the capsid-destabilizing inhibitor PF74. NERT also occurred in HIV-1 particles produced in various T cell lines and in simian immunodeficiency particles. Our results demonstrate that the capsid serves a container role in HIV-1 reverse transcription and suggest that it remains fully intact during reverse transcription in target cells. They further suggest that the gp41 protein can permeabilize membranes to nucleotides, potentially contributing to viral dissemination and pathogenesis in the infected host.

Efficient HIV-1 in vitro reverse transcription: optimal capsid stability is required

The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription

HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products via the cGAS-STING pathway

HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration

Recombination is required for efficient HIV-1 replication and the maintenance of viral genome integrity

Cationic Residues of the HIV-1 Nucleocapsid Protein Enable DNA Condensation to Maintain Viral Core Particle Stability during Reverse Transcription

The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter

HIV-1 Uncoating Occurs via a Series of Rapid Biomechanical Changes in the Core Related to Individual Stages of Reverse Transcription

HIV-1 uncoating requires long double-stranded reverse transcription products

Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS

Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates

Assessment of the susceptibility of mutant HIV-1 to antiviral agents.

Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure

Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA

HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly

HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness

HIV-1 cores retain their integrity until minutes before uncoating in the nucleus

The Retrovirus Capsid Core.

Selective packaging of HIV-1 RNA genome is guided by the stability of 5' untranslated region polyA stem

Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection

HIV-1 single transcription start site mutants display complementary replication functions that are restored by reversion